| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Oct 20, 2025 | CRISPR Therapeutics AG | CEO | Sell | 37.5 | -50,895 | -13.02% | ✗ | $3.5M |
| Oct 13, 2025 | Oct 15, 2025 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -4,242 | -1.44% | ✗ | $282.5K |
| Aug 16, 2025 | Aug 19, 2025 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -13,081 | -4.28% | ✗ | $760.7K |
| Mar 20, 2025 | Mar 24, 2025 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -10,031 | -3.45% | ✗ | $413.6K |
| Mar 10, 2025 | Mar 12, 2025 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -14,435 | -3.10% | ✗ | $616.3K |
| Feb 19, 2025 | Feb 21, 2025 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -18,360 | -6.66% | ✓ | $1M |
| Feb 18, 2025 | Feb 19, 2025 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -18,568 | -6.31% | ✓ | $1M |
| Dec 2, 2024 | Dec 4, 2024 | CRISPR Therapeutics AG | CEO | Sell | 30.0 | -15,000 | -5.32% | ✓ | $826.6K |
| Nov 11, 2024 | Nov 13, 2024 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -30,000 | -9.61% | ✓ | $1.7M |
| Oct 13, 2024 | Oct 15, 2024 | CRISPR Therapeutics AG | CEO | Sell | 42.5 | -4,293 | -1.36% | ✗ | $198.7K |
| Apr 15, 2024 | Apr 17, 2024 | CRISPR Therapeutics AG | CEO | Sell | 32.5 | -19,582 | -4.58% | ✓ | $1.2M |
| Mar 15, 2024 | Mar 18, 2024 | CRISPR Therapeutics AG | CEO | Sell | 32.5 | -20,000 | -4.67% | ✓ | $1.4M |
| Mar 10, 2024 | Mar 12, 2024 | CRISPR Therapeutics AG | CEO | Sell | 37.5 | -14,385 | -2.30% | ✗ | $1.1M |
| Feb 18, 2024 | Feb 21, 2024 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -6,370 | -1.59% | ✗ | $507.5K |
| Feb 15, 2024 | Feb 16, 2024 | CRISPR Therapeutics AG | CEO | Sell | 32.5 | -20,000 | -4.91% | ✓ | $1.6M |
| Jan 29, 2024 | Jan 31, 2024 | CRISPR Therapeutics AG | CEO | Sell | 20.0 | -50,000 | -11.43% | ✓ | $3M |
| Jan 16, 2024 | Jan 18, 2024 | CRISPR Therapeutics AG | CEO | Sell | 32.5 | -20,000 | -4.91% | ✓ | $1.3M |
| May 30, 2023 | Jun 1, 2023 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.06% | ✓ | $1.6M |
| Apr 25, 2023 | Apr 27, 2023 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.06% | ✓ | $1.3M |
| Mar 29, 2023 | Mar 31, 2023 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.06% | ✓ | $1.1M |
| Mar 10, 2023 | Mar 14, 2023 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -9,444 | -1.21% | ✗ | $408.2K |
| Feb 27, 2023 | Mar 1, 2023 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.23% | ✓ | $1.2M |
| Feb 18, 2023 | Feb 22, 2023 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -6,373 | -1.67% | ✗ | $307.6K |
| Jan 27, 2023 | Jan 31, 2023 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.34% | ✓ | $1.3M |
| Dec 28, 2022 | Dec 30, 2022 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -25,000 | -6.34% | ✓ | $1M |
| Dec 3, 2022 | Dec 6, 2022 | CRISPR Therapeutics AG | CEO | Sell | 37.5 | -19,401 | -5.87% | ✗ | $1M |
| Nov 28, 2022 | Nov 30, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.4M |
| Oct 26, 2022 | Oct 28, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.4M |
| Sep 28, 2022 | Sep 30, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.6M |
| Aug 29, 2022 | Aug 31, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.7M |
| Jul 27, 2022 | Jul 29, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.9M |
| Jun 29, 2022 | Jul 1, 2022 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -25,000 | -7.93% | ✓ | $1.5M |
| Mar 10, 2022 | Mar 14, 2022 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -9,640 | -1.65% | ✗ | $596.9K |
| Dec 3, 2021 | Dec 7, 2021 | CRISPR Therapeutics AG | CEO | Sell | 37.5 | -37,818 | -12.64% | ✗ | $2.6M |
| Dec 1, 2021 | Dec 3, 2021 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -779 | -0.35% | ✗ | $58.5K |
| Sep 1, 2021 | Sep 3, 2021 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -787 | -0.42% | ✗ | $98.2K |
| Aug 4, 2021 | Aug 6, 2021 | CRISPR Therapeutics AG | CEO | Sell | 27.5 | -30,000 | -7.40% | ✓ | $3.9M |
| Jun 15, 2021 | Jun 17, 2021 | CRISPR Therapeutics AG | CEO | Sell | 20.0 | -30,000 | -13.78% | ✓ | $3.8M |
| Jun 1, 2021 | Jun 3, 2021 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -779 | -0.41% | ✗ | $90.2K |
| Mar 10, 2021 | Mar 12, 2021 | CRISPR Therapeutics AG | CEO | Sell | 40.0 | -5,526 | -2.85% | ✗ | $686.1K |
| Mar 1, 2021 | Mar 3, 2021 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -798 | -0.44% | ✗ | $103.9K |
| Jan 15, 2021 | Jan 20, 2021 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -20,000 | -9.85% | ✓ | $4.3M |
| Dec 10, 2020 | Dec 11, 2020 | CRISPR Therapeutics AG | CEO | Sell | 20.0 | -20,000 | -10.57% | ✓ | $2.8M |
| Dec 1, 2020 | Dec 3, 2020 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -779 | -0.46% | ✗ | $100.9K |
| Sep 2, 2020 | Sep 3, 2020 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -779 | -0.46% | ✗ | $73.3K |
| Jun 1, 2020 | Jun 3, 2020 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -18,054 | -9.56% | ✓ | $1.2M |
| May 19, 2020 | May 21, 2020 | CRISPR Therapeutics AG | CEO | Sell | 35.0 | -15,000 | -4.19% | ✓ | $978.7K |
| Mar 2, 2020 | Mar 4, 2020 | CRISPR Therapeutics AG | CEO | Sell | 51.3 | -794 | -0.46% | ✗ | $41.9K |
| Dec 1, 2019 | Dec 2, 2019 | CRISPR Therapeutics AG | CEO | Sell | 47.5 | -741 | -0.45% | ✗ | $53.1K |
| Sep 1, 2019 | Sep 3, 2019 | CRISPR Therapeutics AG | CEO | Sell | 51.3 | -740 | -0.45% | ✗ | $34.2K |
| Jun 17, 2019 | Jun 19, 2019 | CRISPR Therapeutics AG | CEO | Sell | 22.5 | -20,000 | -10.76% | ✓ | $920K |
| Jun 1, 2019 | Jun 4, 2019 | CRISPR Therapeutics AG | CEO | Sell | 51.3 | -741 | -0.44% | ✗ | $26.4K |
| Apr 29, 2019 | May 1, 2019 | CRISPR Therapeutics AG | CEO | Sell | 22.5 | -20,000 | -10.72% | ✓ | $840.6K |
| Mar 1, 2019 | Mar 5, 2019 | CRISPR Therapeutics AG | CEO | Sell | 51.3 | -748 | -0.45% | ✗ | $29.9K |
| Dec 1, 2018 | Dec 3, 2018 | CRISPR Therapeutics AG | CEO | Sell | 48.8 | -741 | -0.51% | ✗ | $28.4K |
| Sep 1, 2018 | Sep 4, 2018 | CRISPR Therapeutics AG | CEO | Sell | 48.8 | -741 | -0.50% | ✗ | $42K |
| Jun 1, 2018 | Jun 5, 2018 | CRISPR Therapeutics AG | CEO | Sell | 23.8 | -15,741 | -9.62% | ✓ | $1.1M |
| Aug 28, 2017 | Aug 30, 2017 | CRISPR Therapeutics AG | Chief Business Officer | Sell | 12.5 | -27,154 | -20.26% | ✓ | $545.2K |
| Apr 26, 2017 | Apr 28, 2017 | CRISPR Therapeutics AG | Chief Business Officer | Sell | 41.3 | -5,481 | -2.00% | ✓ | $91.8K |
| Apr 21, 2017 | Apr 25, 2017 | CRISPR Therapeutics AG | Chief Business Officer | Sell | 41.3 | -11,615 | -2.81% | ✓ | $194.9K |
| Apr 19, 2017 | Apr 21, 2017 | CRISPR Therapeutics AG | Chief Business Officer | Sell | 41.3 | -10,058 | -2.43% | ✓ | $178.4K |